FDA
Pharma

Replimune secures FDA approval after long regulatory battle

The accelerated approval does not mean Replimune’s fate has completely reversed, as the company is still required to provide confirmatory data.
Angus Liu Aug 6, 2026 4:41pm
Why the Real Risk in Hub Transition is Inertia

What Hub Transitions Really Cost Manufacturers

Brought to you by Gifthealth
milestones

Sarepta's new CEO faces critical tests to prove growth

Aug 6, 2026 11:15am
Takeda

FDA approves Takeda's first-in-class Orzeyful for narcolepsy

Aug 6, 2026 11:10am
ViiV do it for future you campaign

ViiV targets ‘future you’ in long-acting HIV campaign

Aug 6, 2026 8:46am
dupixent

Sanofi asked to change Dupixent ads after Galderma challenge

Aug 6, 2026 7:40am
More News

Moderna's mRNA flu shot nabs FDA nod after earlier review hiccup

Aug 5, 2026 11:36pm

Narcan maker Emergent axes top R&D post in sweeping restructuring

Aug 5, 2026 8:16pm

AstraZeneca, CSPC to form manufacturing joint venture

Aug 5, 2026 3:22pm

Alcon survey spots gaps in teen eye care

Aug 5, 2026 2:06pm